New Age Alpha Advisors LLC Purchases New Holdings in Doximity, Inc. (NASDAQ:DOCS)

New Age Alpha Advisors LLC acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 9,087 shares of the company's stock, valued at approximately $485,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DOCS. Vanguard Group Inc. grew its position in shares of Doximity by 4.5% in the fourth quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock valued at $598,159,000 after purchasing an additional 485,102 shares in the last quarter. State Street Corp boosted its stake in Doximity by 2.5% in the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company's stock worth $160,947,000 after purchasing an additional 88,922 shares during the period. Geode Capital Management LLC grew its holdings in Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock valued at $124,503,000 after buying an additional 472,565 shares in the last quarter. Loomis Sayles & Co. L P increased its position in shares of Doximity by 2.7% during the fourth quarter. Loomis Sayles & Co. L P now owns 2,334,597 shares of the company's stock valued at $124,644,000 after buying an additional 62,366 shares during the period. Finally, Los Angeles Capital Management LLC lifted its holdings in shares of Doximity by 33.7% in the fourth quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company's stock worth $46,466,000 after buying an additional 219,448 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Down 6.1 %

Shares of DOCS traded down $3.35 during mid-day trading on Friday, hitting $51.23. 2,945,730 shares of the company's stock traded hands, compared to its average volume of 1,953,990. The firm has a market capitalization of $9.56 billion, a P/E ratio of 51.23, a PEG ratio of 4.10 and a beta of 1.41. The business's 50-day moving average price is $65.50 and its 200-day moving average price is $55.12. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on DOCS shares. Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and upped their target price for the stock from $31.00 to $78.00 in a report on Friday, February 7th. The Goldman Sachs Group upped their price target on shares of Doximity from $58.00 to $80.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Canaccord Genuity Group lifted their price objective on Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research note on Friday, February 7th. Stephens began coverage on Doximity in a research note on Friday, December 20th. They issued an "equal weight" rating and a $55.00 target price on the stock. Finally, Needham & Company LLC lifted their price target on Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $64.22.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 37.40% of the company's stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.